Dr. Jove Graham, Research Investigator I, Geisinger Center for Health Research, Danville, PA, discusses the Post-Discharge Monitoring and Readmissions study. In this clip, Dr. Graham provides background and how this study differs from others Geisinger has conducted.
The program attempted to prevent patients from being re-admitted or going to the ER within 30 days of discharge using the telemonitoring program.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen